The meeting between members of the Joint Parliamentary Committee (JPC) on the Waqf (Amendment) Bill, 2024 and Lok Sabha ...

Ultragenyx Pharmaceutical is a mid-cap biotech firm with a promising pipeline and an optimistic outlook from analysts. Click ...

Weill Cornell Medicine investigators have identified in a preclinical model a specific brain circuit whose inhibition appears ...

Discover how terrorist groups in Pakistan manipulate social media to spread propaganda and undermine national security efforts.

Recent attacks by BLA and BLF in Balochistan claim civilian lives. Details on incidents, victim accounts, and security ...

Fifty years ago today, the Puerto Rican separatist group, the FALN, bombed Manhattan's historic Fraunces Tavern, but no one has ever been charged in the attack.

Larimar Therapeutics, Inc. (NASDAQ:LRMR), with a market capitalization of $228 million, is a clinical-stage biopharmaceutical ...

Replimune Group Inc (NASDAQ:REPL), a biotechnology company specializing in oncolytic immunotherapy for cancer treatment with a current market capitalization of $803 million, has been making ...

The trial evaluated ONS-5010 in wet age-related macular degeneration patients, and the company plans to resubmit a Biologics ...

TEMPO.CO, Jakarta - Minister of Housing and Settlements Maruarar Sirait, or Ara, will build housing units for members of the Indonesian Army (TNI-AD), in collaboration with the Public Housing Savings ...

Outlook Therapeutics plans to resubmit the Biologics License Application (BLA) for ONS-5010 in the first quarter of calendar 2025. Julia A. Haller, MD, Ophthalmologist-in-Chief at Wills Eye Hospital ...